Bio-Thera Announces Promising Clinical Data for BAT8008 in Combination with BAT1308 in First Line Non-Small Cell Lung Cancer at ESMO 2026

Summary

GUANGZHOU, China, Oct. 24, 2026 — Bio-Thera Solutions, Ltd. (688177. SH), a commercial stage biopharmaceutical company developing innovative therapies and biosimilars, today announced the presentation of...